Alumis (ALMS) Shares Outstanding (Weighted Average) (2023 - 2025)

Alumis (ALMS) reported Shares Outstanding (Weighted Average) of $85.0 million for Q4 2025, up 197.51% year-over-year from $28.6 million in Q4 2024, and up 8.24% quarter-over-quarter from $78.6 million in Q3 2025.

Alumis (ALMS) Shares Outstanding (Weighted Average) (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Shares Outstanding (Weighted Average) data on file, last reported at $85.0 million in Q4 2025.

  • Shares Outstanding (Weighted Average) for Q4 2025 came in at $85.0 million, up 197.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $85.0 million (up 197.51% YoY), and the FY2025 annual result was $85.0 million, up 197.51% from the prior year.
  • Shares Outstanding (Weighted Average) climbed to $85.0 million in Q4 2025 per ALMS's latest filing, from $78.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $85.0 million in Q4 2025 and troughed at $2.1 million in Q3 2023.
  • A 3-year average of $35.3 million and a median of $28.6 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) decreased 7.21% in 2024, then surged 3029.96% in 2025.
  • A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $2.2 million in 2023, then jumped by 1229.19% to $28.6 million in 2024, then surged by 197.51% to $85.0 million in 2025.
  • Business Quant data shows ALMS's Shares Outstanding (Weighted Average) at $85.0 million in Q4 2025, $78.6 million in Q3 2025, and $76.6 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Alumis 1.99 Bn 1.90 Bn - 85.03 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 85.03 Mn
Sep 30, 2025 78.55 Mn
Jun 30, 2025 76.56 Mn
Mar 31, 2025 54.41 Mn
Dec 31, 2024 28.58 Mn
Sep 30, 2024 53.97 Mn
Jun 30, 2024 2.45 Mn
Mar 31, 2024 2.37 Mn
Dec 31, 2023 2.15 Mn
Sep 30, 2023 2.10 Mn
Jun 30, 2023 2.64 Mn